BR220737 - SeCore CDx HLA Sequencing System
De Novo Number: BR220737
Applicant: One Lambda Inc.
Device Name: SeCoreTM CDx HLA Sequencing System
Decision Date: 11/28/2022
On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.
De Novo Number: BR220737
Applicant: One Lambda Inc.
Device Name: SeCoreTM CDx HLA Sequencing System
Decision Date: 11/28/2022